Company: LRHC
Filing Date: 2025-09-25
Form Type: S-1
Source: 0001213900-25-091637
Chunk: 42

Company: La Rosa Holdings Corp.
Filing Date: 2025-09-25
Form: S-1
Chunk 42
---
 align='center'>22

USE OF PROCEEDS</div>

This Prospectus relates to the shares of our common
stock that may be offered and resold from time to time by the Selling Stockholder. See “Plan of Distribution” elsewhere
in this Prospectus for more information. All of the shares of common stock offered by the Selling Stockholder pursuant to this Prospectus
will be sold by the Selling Shareholder for its respective account. We will not receive any of the proceeds from these sales.

We may receive up to $850,000,000 in aggregate
gross proceeds from sales of shares of our common stock we make to the Selling Stockholder under the Amended Facility Agreement (excluding
the gross proceeds for the shares issuable pursuant to the Existing Facility Agreement). We may choose to sell fewer than $850,000,000
in shares of our common stock, or, due to the Exchange Cap and/or the beneficial ownership limitation, we may not be able to sell all
$850,000,000 in shares of our common stock under the Amended Facility Agreement, in which case we would raise less than $850,000,000 in
aggregate gross proceeds under the Amended Facility Agreement. It is also possible that we do not sell any shares of our common stock
under the Facility.

The Company has broad discretion in the use of
the net proceeds from any sales of shares of our common stock to the Selling Stockholder under the Facility. Based upon our current plans
and business conditions, we intend to use the net proceeds from such sales to, without limitation, for working capital and general corporate
purposes. We have not determined the amount of net proceeds to be used specifically for any such purposes. The amounts and timing of our
actual expenditures may vary significantly and will depend on numerous factors, including market conditions, cash generated or used by
our operations, business developments, industry developments and opportunities that may arise. We may find it necessary or advisable to
use portions of the proceeds we receive from our sales of shares of common stock to the Selling Stockholder under the Facility for other
purposes.

We will bear all of the costs, fees and expenses
incurred in effecting the registration of the Shares covered by this Prospectus, including, without limitation, the registration and filing
fees, printing fees, Nasdaq listing fees and fees and expenses of our counsel and our accountants. The Selling Stockholder will bear all
commissions and discounts, if any, attributable to the resale